Form 8-K - Current report:
SEC Accession No. 0001193125-26-267487
Filing Date
2026-06-11
Accepted
2026-06-11 16:05:16
Documents
9
Period of Report
2026-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20260611.htm   iXBRL 8-K 66632
  Complete submission text file 0001193125-26-267487.txt   176283

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20260611.xsd EX-101.SCH 27183
13 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20260611_htm.xml XML 4762
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 261083019
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)